IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,991 | -15.5% | 7,164,209 | -6.6% | 0.16% | -11.1% |
| Q2 2023 | $81,612 | +2.4% | 7,670,309 | +1.2% | 0.18% | +0.6% |
| Q1 2023 | $79,717 | -18.8% | 7,577,709 | -4.4% | 0.18% | -17.5% |
| Q4 2022 | $98,208 | -99.9% | 7,926,397 | +0.2% | 0.22% | +12.4% |
| Q3 2022 | $81,991,000 | -4.9% | 7,914,220 | +5.8% | 0.19% | +3.8% |
| Q2 2022 | $86,235,000 | -7.5% | 7,479,157 | +1.0% | 0.19% | +8.8% |
| Q1 2022 | $93,184,000 | +6.5% | 7,407,330 | -1.3% | 0.17% | +10.3% |
| Q4 2021 | $87,536,000 | -14.2% | 7,507,406 | -3.9% | 0.16% | -15.8% |
| Q3 2021 | $102,027,000 | +81.6% | 7,812,227 | +79.0% | 0.18% | +93.7% |
| Q2 2021 | $56,167,000 | +415.8% | 4,364,227 | +348.1% | 0.10% | +400.0% |
| Q1 2021 | $10,889,000 | – | 973,999 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |